Status:
COMPLETED
Pharmacogenetics of Hypertriglyceridemia in Hispanics
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Heart Diseases
Eligibility:
All Genders
18-100 years
Brief Summary
To study the effect of genes on lipid-lowering drug treatment in hypertriglyceridemia.
Detailed Description
BACKGROUND: Increased serum triglycerides are a significant independent risk factor for coronary artery disease and myocardial infarction. Besides typical lifestyle modification, the treatment with f...
Eligibility Criteria
Inclusion
- Hispanics with hypertriglyceridemia
Exclusion
Key Trial Info
Start Date :
July 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
274 Patients enrolled
Trial Details
Trial ID
NCT00086437
Start Date
July 1 2004
End Date
January 1 2010
Last Update
December 3 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.